Swiss Dermatology Network of Targeted Therapies (SDNTT)
NCT01706692
Summary
The purpose of this study is to evaluate the long-term course of patients with psoriasis and psoriatic-arthritis in systemic treatments such as, methotrexate, cyclosporin A, fumaric acids, acitretin, systemic PUVA, etanercept, infliximab, adalimumab and ustekinumab. A patient will be included at first initiation of the treatment and will remain in the registry for 10 years, regardless of subsequent therapy. The registry will also evaluate safety clinical outcomes and health related quality of life.
Eligibility
Inclusion Criteria: * Patients with diagnosis of plaque-type psoriasis or psoriasis arthritis confirmed by a dermatologist, * age ≥ 18, * Being administered a specific biologic/conventional systemic drug for the first time * Sufficient language skills (German, French, Italian and English) for the informed consent to participate * Informed consent to participate Exclusion Criteria: * Lack of informed consent * Patients being participants of clinical trials at the day of registration to the registry (if a patient is included into a clinical trial during the registry follow-ups, the patient data will be recorded, but analyzed separately)
Conditions2
Interventions8
Related trials
- Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis — Tom Appleton
- Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA) — Universita di Verona
- A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab — AbbVie
- A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes — City of Hope Medical Center
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response — University of Nebraska
- Cyclosporine In Takotsubo Syndrome — University Hospital Heidelberg
- Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders — Memorial Sloan Kettering Cancer Center
- Advanced Therapeutics in Rheumatoid Arthritis (RA) — London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT01706692